Form 8-K - Current report:
SEC Accession No. 0001104659-04-001830
Filing Date
2004-01-27
Accepted
2004-01-27 16:15:27
Documents
4
Period of Report
2004-01-27
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-1567_18k.htm 8-K 17374
3 EX-5.1 a04-1567_1ex5d1.htm EX-5.1 7396
4 EX-99.1 a04-1567_1ex99d1.htm EX-99.1 11589
5 GRAPHIC g15671kkimage002.jpg GRAPHIC 6496
  Complete submission text file 0001104659-04-001830.txt   44820
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 04546577
SIC: 2836 Biological Products, (No Diagnostic Substances)